Back to Search
Start Over
Novel Therapies for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma: A Review of Clinical Trials
- Source :
- Blood; November 2020, Vol. 136 Issue: Supplement 1 p43-44, 2p
- Publication Year :
- 2020
-
Abstract
- Anwer: Incyte, Seattle Genetics, Acetylon Pharmaceuticals, AbbVie Pharma, Astellas Pharma, Celegene, Millennium Pharmaceuticals.: Honoraria, Research Funding, Speakers Bureau.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 136
- Issue :
- Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs54553812
- Full Text :
- https://doi.org/10.1182/blood-2020-142903